Capecitabine-Based Treatment of a Patient With a Novel DPYD Genotype and Complete Dihydropyrimidine Dehydrogenase Deficiency

International Journal of Cancer - United States
doi 10.1002/ijc.31065
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Dihydropyrimidine Dehydrogenase Deficiency as a Cause of Fatal 5-Fluorouracil Toxicity

Autopsy and Case Reports
2018English

Dihydro Pyrimidine Dehydrogenase Deficiency in Patients Treated With Capecitabine Based Regimens: A Tertiary Care Centre Experience

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

Dihydropyrimidine Dehydrogenase Deficiency: Metabolic Disease or Biochemical Phenotype?

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2017English

SNPs and Haplotypes in DPYD and Outcome of Capecitabine-Letter

Clinical Cancer Research
Cancer ResearchOncology
2011English

Undetectable Levels of CSF Amyloid-Β Peptide in a Patient With 17β-Hydroxysteroid Dehydrogenase Deficiency

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2011English

Dihydropyrimidine Dehydrogenase Gene Variation and Severe 5-Fluorouracil Toxicity: A Haplotype Assessment

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2009English

Acute Chest Pain in a Patient Treated With Capecitabine

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2009English

A Patient With Organizing Pneumonia Development During the Use of Capecitabine Maintenance Treatment for Gastric Cancer

Respiratory Case Reports
2016English

Rapid Liver Disease Progression in a Patient With Homozygous Alpha1-Antitrypsin Deficiency (Pi*ZZ Genotype)

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy